메뉴 건너뛰기




Volumn 96, Issue 11, 2012, Pages 1410-1414

Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

EID: 84868007873     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-301857     Document Type: Article
Times cited : (20)

References (17)
  • 2
    • 0035025345 scopus 로고    scopus 로고
    • Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature
    • Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647-52.
    • (2001) Am J Ophthalmol , vol.131 , pp. 647-652
    • Read, R.W.1    Holland, G.N.2    Rao, N.A.3
  • 3
    • 33745640944 scopus 로고    scopus 로고
    • Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease
    • Read RW, Yu F, Accorinti M, et al. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2006;142:119-24.
    • (2006) Am J Ophthalmol , vol.142 , pp. 119-124
    • Read, R.W.1    Yu, F.2    Accorinti, M.3
  • 4
    • 0030995211 scopus 로고    scopus 로고
    • Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis
    • Barnes D, Hughes RA, Morris RW, et al. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet 1997; 349:902-6.
    • (1997) Lancet , vol.349 , pp. 902-906
    • Barnes, D.1    Hughes, R.A.2    Morris, R.W.3
  • 5
    • 70149121896 scopus 로고    scopus 로고
    • Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
    • Burton JM, O'Connor PW, Hohol M, et al. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database Syst Rev 2009: CD006921.
    • (2009) Cochrane Database Syst Rev
    • Burton, J.M.1    O'Connor, P.W.2    Hohol, M.3
  • 6
    • 0027401041 scopus 로고
    • Is intravenous glucocorticoid therapy better than an oral regimen for asymptomatic cardiac rejection? A randomized trial
    • Kobashigawa JA, Stevenson LW, Moriguchi JD, et al. Is intravenous glucocorticoid therapy better than an oral regimen for asymptomatic cardiac rejection? A randomized trial. J Am Coll Cardiol 1993;21:1142-4.
    • (1993) J Am Coll Cardiol , vol.21 , pp. 1142-1144
    • Kobashigawa, J.A.1    Stevenson, L.W.2    Moriguchi, J.D.3
  • 7
    • 79952315688 scopus 로고    scopus 로고
    • Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease
    • Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina 2011;31:510-17.
    • (2011) Retina , vol.31 , pp. 510-517
    • Maruko, I.1    Iida, T.2    Sugano, Y.3
  • 8
    • 34447645669 scopus 로고    scopus 로고
    • Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease
    • Yamaguchi Y, Otani T, Kishi S. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2007;144:260-5.
    • (2007) Am J Ophthalmol , vol.144 , pp. 260-265
    • Yamaguchi, Y.1    Otani, T.2    Kishi, S.3
  • 9
    • 78751642081 scopus 로고    scopus 로고
    • Optical coherence tomographic assessment of dynamic macular changes in patients with Vogt-Koyanagi-Harada disease
    • Ikewaki J, Kimoto K, Choshi T, et al. Optical coherence tomographic assessment of dynamic macular changes in patients with Vogt-Koyanagi-Harada disease. Int Ophthalmol 2011;31:9-13.
    • (2011) Int Ophthalmol , vol.31 , pp. 9-13
    • Ikewaki, J.1    Kimoto, K.2    Choshi, T.3
  • 10
    • 69249212221 scopus 로고    scopus 로고
    • Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography
    • Ishihara K, Hangai M, Kita M, et al. Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography. Ophthalmology 2009;116:1799-807.
    • (2009) Ophthalmology , vol.116 , pp. 1799-1807
    • Ishihara, K.1    Hangai, M.2    Kita, M.3
  • 11
    • 70249084234 scopus 로고    scopus 로고
    • Edema of the photoreceptor layer in Vogt-Koyanagi-Harada disease observed using high-resolution optical coherence tomography
    • Lee JE, Park SW, Lee JK, et al. Edema of the photoreceptor layer in Vogt-Koyanagi-Harada disease observed using high-resolution optical coherence tomography. Korean J Ophthalmol 2009;23:74-9.
    • (2009) Korean J Ophthalmol , vol.23 , pp. 74-79
    • Lee, J.E.1    Park, S.W.2    Lee, J.K.3
  • 12
    • 79952306835 scopus 로고    scopus 로고
    • Inner retinal changes in acute-phase Vogt-Koyanagi-Harada disease measured by enhanced spectral domain optical coherence tomography
    • Yamamoto M, Nishijima K, Nakamura M, et al. Inner retinal changes in acute-phase Vogt-Koyanagi-Harada disease measured by enhanced spectral domain optical coherence tomography. Jpn J Ophthalmol 2011;55:1-6.
    • (2011) Jpn J Ophthalmol , vol.55 , pp. 1-6
    • Yamamoto, M.1    Nishijima, K.2    Nakamura, M.3
  • 13
    • 0025855096 scopus 로고
    • Vogt-Koyanagi-Harada syndrome, Clinical course, therapy, and long-term visual outcome
    • Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 1991;109:682-7.
    • (1991) Arch Ophthalmol , vol.109 , pp. 682-687
    • Rubsamen, P.E.1    Gass, J.D.2
  • 14
    • 59149086588 scopus 로고    scopus 로고
    • Management of ocular complications of Vogt-Koyanagi-Harada syndrome
    • Perente I, Utine CA, Cakir H, et al. Management of ocular complications of Vogt-Koyanagi-Harada syndrome. Int Ophthalmol 2009;29:33-7.
    • (2009) Int Ophthalmol , vol.29 , pp. 33-37
    • Perente, I.1    Utine, C.A.2    Cakir, H.3
  • 15
    • 81055129593 scopus 로고    scopus 로고
    • Intravitreal triamcinolone acetonide for rebound phenomenon after high-dose intravenous steroid treatment in Vogt-Koyanagi-Harada disease
    • Byon IS, Kim JH, Lee JE, et al. Intravitreal triamcinolone acetonide for rebound phenomenon after high-dose intravenous steroid treatment in Vogt-Koyanagi-Harada disease. Clin Ophthalmol 2011;5:1589-91.
    • (2011) Clin Ophthalmol , vol.5 , pp. 1589-1591
    • Byon, I.S.1    Kim, J.H.2    Lee, J.E.3
  • 16
    • 72449152649 scopus 로고    scopus 로고
    • Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease
    • Khalifa Y, Loh AR, Acharya NR. Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm 2009;17:431-3.
    • (2009) Ocul Immunol Inflamm , vol.17 , pp. 431-433
    • Khalifa, Y.1    Loh, A.R.2    Acharya, N.R.3
  • 17
    • 84857112402 scopus 로고    scopus 로고
    • Comparison of manually corrected retinal thickness measurements from multiple spectral-domain optical coherence tomography instruments
    • Heussen FM, Ouyang Y, McDonnell EC, et al. Comparison of manually corrected retinal thickness measurements from multiple spectral-domain optical coherence tomography instruments. Br J Ophthalmol 2012;96:380-5.
    • (2012) Br J Ophthalmol , vol.96 , pp. 380-385
    • Heussen, F.M.1    Ouyang, Y.2    McDonnell, E.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.